OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

GrowGeneration Misses Revenue Forecast and Cuts Outlook

GrowGeneration Reports Second Quarter 2023 Financial Results Net Revenue of $63.9 million Represents a 12% Sequential Improvement from Prior Quarter Net Loss of $5.7 million

August 9, 2023

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Insilico Medicine reported Phase 2a results for its lead program, saying the study achieved its primary endpoint of safety and tolerability. But the efficacy data

September 19, 2024

A primer on HELIOS-B, an enormous stock-moving event for Alnylam Pharmaceuticals

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.